dentification of bone involvement in patients with prostate cancer recurrence using 18F-fluciclovine PET/CT and impact on subsequent management.

被引：0
|
作者：
Kipper, Michael S.
Dato, Paul
机构：
[1] Genesis Healthcare, San Diego, CA USA
[2] Genesis Healthcare Partners, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] The diagnostic role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the detection of prostate cancer with biochemical recurrence
    Wang, Rang
    Tian, Rong
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [42] PSA LEVEL PREDICTS POSITIVITY OF 18F-FLUCICLOVINE PET/CT IN PATIENTS WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER
    Sathianathen, Niranjan
    Genturk, Mehmet
    Salavati, Ali
    Konety, Badrinath
    Froelich, Jerry
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1162 - E1162
  • [43] PSA Level Predicts Positivity of 18F-Fluciclovine PET/CT in Patients with Biochemically Recurrent Prostate Cancer
    Sathianathen, Niranjan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 63 - 63
  • [44] Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer
    Teoh, Eugene J.
    Tsakok, Maria T.
    Bradley, Kevin M.
    Hyde, Katherine
    Subesinghe, Manil
    Gleeson, Fergus V.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 803 - 804
  • [45] Detectability Rates and Impact on Management From High-Sensitivity Total-Body 18F-Fluciclovine PET/CT Scans in Patients With Prostate Cancer Biochemical Recurrence
    Azghadi, S.
    Abdelhafez, Y.
    Parikh, M.
    Stephen, M.
    Usera, B. M.
    Dall'Era, M.
    Badawi, R.
    Cherry, S.
    Zhao, X.
    Sen, F. Comma
    Nardo, L.
    Valicenti, R. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E264 - E265
  • [46] 18F-fluciclovine (Axumin) PET/CT detecting occult bone metastasis
    Pankaj Nepal
    Paul Rodrigue
    Thomas Olsavsky
    Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [47] Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
    Bach-Gansmo, Tore
    Korsan, Katrine
    Bogsrud, Trond Velde
    TOMOGRAPHY, 2022, 8 (03) : 1477 - 1484
  • [48] The FALCON trial: Impact of 18F-fluciclovine PET/CT on clinical management choices for men with biochemically recurrent prostate cancer.
    Teoh, Eugene Jueren
    Bottomley, David M.
    Scarsbrook, Andrew
    Payne, Heather
    Afaq, Asim
    Bomanji, Jamshed
    Van As, Nick
    Chua, Sue
    Hoskin, Peter
    Chambers, Anthony
    Cook, Gary J.
    Warbey, Victoria S.
    Chau, Albert
    Ward, Penelope
    Miller, Matthew P.
    Stevens, Daniel J.
    Wilson, Lynn
    Gleeson, Fergus V.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [49] Negative 18F-Piflufolastat PET/CT, But Positive 18F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer
    Ulaner, Gary A.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 968 - 970
  • [50] 18F-fluciclovine PET/CT in comparison with 11C-Choline PET/CT for nodal staging in prostate cancer patients
    Zanoni, Lucia
    Bossert, Irene
    Nanni, Cristina
    Pultrone, Cristian
    Schiavina, Riccardo
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Porreca, Angelo
    Fonti, Cristina
    Bianchi, Lorenzo
    Matti, Antonella
    Brunocilla, Eugenio
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345